Last reviewed · How we verify
NCT06346379
The Effect of Baduanjin on Physical Fitness and Bone Density in Maintenance Hemodialysis Patients
NA trial testing Baduanjin exercise in Rehabilitation in 50 participants. Status unknown.
1 October 2025
Quick facts
| Lead sponsor | Affiliated Hospital of Nantong University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 April 2024 |
| Primary completion | 1 October 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Baduanjin exercise
Conditions studied
- Rehabilitation — all drugs for Rehabilitation →
- Physical Fitness — all drugs for Physical Fitness →
- Bone Density — all drugs for Bone Density →
- Hemodialysis Complication — all drugs for Hemodialysis Complication →
Sponsor
Affiliated Hospital of Nantong University
Who can join
Adults 18 to 75, any sex, with Rehabilitation or Physical Fitness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to examine the effect of 18-month Baduanjin exercise on physical fitness and bone density in maintenance hemodialysis (MHD) patients. 50 MHD patients aged 18-75 will included in this study and randomly divided into two groups (intervention group and control group). The intervention group will be led by a professional person and underwent Baduanjin exercise three times a week before hemodialysis. The control group maintained routine treatment and daily activities.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06346379
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Baduanjin exercise
Trials testing the same drug.
- NCT07482995 — Effects of Baduanjin Exercise on Improving Health in Sedentary Young and Middle-Aged Adults · NA · not yet recruiting
- NCT07163676 — Is There a Response of Glaucoma to Baduanjin Exercise in Elders? · NA · recruiting
- NCT06179810 — Effect of Baduanjin Exercise on Metabolic Syndrome Patients · NA · unknown
- NCT06314321 — The Effect of Baduanjin on Shoulder Function in Maintenance Hemodialysis Patients · NA · completed
- NCT03229681 — Baduanjin Exercise for Patients With Chronic Heart Failure on Phase II Cardiac Rehabilitation · NA · unknown
Other recruiting trials for Rehabilitation
Currently open trials in the same condition.
- NCT07450274 — Rehabilitation of Upper Limbs After Stroke · NA · recruiting
- NCT07419217 — Professional Impact of Osteoarticular Trauma · recruiting
- NCT07399262 — Music-Augmented Rhythmic Gait Training in Multiple Sclerosis · NA · recruiting
- NCT07333079 — Rehabilitation With Biofeedback for People After Stroke · NA · recruiting
- NCT07304180 — Exergame vs Balance Training in Hemiplegia · NA · active not recruiting
Other Affiliated Hospital of Nantong University trials
Trials by the same sponsor.
- NCT07506668 — RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas · Phase 1, PHASE2 · not yet recruiting
- NCT07342283 — QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer · Phase 2 · recruiting
- NCT07382453 — Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases · Phase 2 · not yet recruiting
- NCT07247838 — Prospective Cohort Control Study on Changes in Gut Microbiota in Ischemic Stroke · recruiting
- NCT07271147 — Effects of taVNS Combined With Dexmedetomidine on POVN · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06346379 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Affiliated Hospital of Nantong University
- Last refreshed: 14 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06346379.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing